Ceres Aktie $$$ NEWS $$$ WKN: A14RPB ISIN: US1567734009 Symbol: CERE Typ: Aktie http

[JohnJohnson]

Ceres Aktie $$$ NEWS $$$
WKN: A14RPB
ISIN: US1567734009
Symbol: CERE
Typ: Aktie





Ceres Awarded Patent for Innovation in Soybean
Date : 05/27/2015 @ 7:45AM
Source : PR Newswire (US)
Stock : Ceres, Inc. (MM) (CERE)
Quote : 3.77 2.09 (124.40%) @ 12:00PM

Ceres Awarded Patent for Innovation in Soybean
Print
Ceres, Inc. (MM) (NASDAQ:CERE)
Intraday Stock Chart

Today : Wednesday 27 May 2015
Click Here for more Ceres, Inc. (MM) Charts.

THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, has been awarded a U.S. patent for a genetic sequence derived from soybean, covering uses of the gene in areas such as research, product development and plant transformation. The company believes that its gene is useful in regulating key biosynthetic processes that are the target of a class of commercial herbicides. Ceres plans to offer other seed companies a commercial license to the innovation, including an opportunity for exclusivity in certain crops.

Richard Hamilton, President and CEO of Ceres, said that the company is currently evaluating the potential market for this gene among soybean seed companies and the use of its patented invention in the development and production of improved soybean varieties.

Ceres' biotechnology platform, which has proven to increase crop productivity, raise quality, reduce crop inputs and improve cultivation on marginal land, has broad application across multiple markets and crops.

Hamilton noted that growers are facing increasing demand for food, feed, fiber and fuel as a result of rising global population and an expanding middle class in certain regions. "The need for technology improvements has become more pressing due to stresses from climate variability and competition for water resources," said Hamilton. "Agricultural biotechnology has and will continue to represent a significant source of innovation for increasing crop yields through improving performance of seeds."

The new patent for this invention was issued by the U.S. Patent and Trademark Office as U.S. Patent No. 9,024,004 and is titled, Sequence-Determined DNA Fragments Encoding Acetohydroxyacid Synthase Proteins. Ceres owns or maintains exclusive licensed rights to approximately 85 issued patents and numerous pending patent applications in the United States and in various foreign jurisdictions. A patent is an intellectual property right granted by a government to an inventor to exclude others from making, using, offering for sale, or selling the invention for a limited time in exchange for public disclosure of the invention when the patent is granted.

Soybean is one of the most valuable and widely planted row crops in the world. From 2003 to 2013, the number of acres planted increased 2.4% annually, to 275 million acres today, according to the Food and Agriculture Organization of the United Nations. Soybeans are used for oil, feed for livestock and aquaculture, as a biofuel feedstock and as a protein for the human diet.

About Ceres
Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for forage, biofuels and other markets that utilize plant biomass. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.

Ceres Forward-Looking Statements
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products and technologies, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's plan to align expenditures and projected cash expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

To view the original version on PR Newswire, visit:

SOURCE Ceres, Inc.

Copyright 2015 PR Newswire

[JohnJohnson]

Ceres skyrockets after winning U.S. patent for soybean innovation
May 27 2015, 14:11 ET | By: Carl Surran, SA News Editor [Contact this editor with comments or a news tip]

Ceres (CERE +101.8%) shares more than double after the agricultural biotech company says it received a U.S. patent for a genetic sequence derived from soybeans affecting plant development and transformation such as boosting yields or adapting soybeans for biofuel production.
CERE believes the gene has applications in regulating major biosynthetic practices related to commercial herbicides, and aims to market a commercial license for its innovation to other seed businesses, which also includes an option for exclusivity in specific crops.
CERE says soybean is one of the most popular and profitable cash crops in the world, as the number of acres farmers planted increased 2.4%/year during 2003-13 to 275M acres worldwide.

765 people get CERE breaking news and analysis by email alert.